Literature DB >> 8115157

Risk factors in the development of ocular surface epithelial dysplasia.

G A Lee1, G Williams, L W Hirst, A C Green.   

Abstract

BACKGROUND: Ocular surface epithelial dysplasia involves a spectrum of diseases ranging from only minor eye irritation to blindness and potentially death.
METHODS: A case-control study involving 60 patients with ocular surface epithelial dysplasia treated between 1972 and 1991 and 60 age- and sex-matched individuals was conducted to compare relative ultraviolet light exposures over their lifetimes. A standardized self-administered ultraviolet exposure questionnaire was used for assessment.
RESULTS: Risk factors identified include phenotypic features such as fair skin (odds ratio [OR], 5.4; 95% confidence interval [CI], 1.1, 25.6), pale iris (OR, 1.8; 95%; CI, 0.9, 3.8), and propensity to sunburn (OR, 3.8; 95% CI, 0.7, 19.7), history of previous skin cancers removed (OR, 15; 95% CI, 2.0, 113.6), and being outdoors more than 50% of time in the first 6 years of life while living 30 degrees or less from the equator (OR, 7.5; 95% CI, 1.8, 30.6).
CONCLUSION: These risk factors suggest that ocular surface epithelial dysplasia is an ultraviolet light-related disease.

Entities:  

Mesh:

Year:  1994        PMID: 8115157     DOI: 10.1016/s0161-6420(94)31328-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  32 in total

1.  Total regression of extensive conjunctival intraepithelial neoplasia with superficial corneal invasion treated with topical mitomycin C 0.02%.

Authors:  Marta Calatayud; Josep Badal; Laia Bisbe; Sara Martin; Javier Puig
Journal:  BMJ Case Rep       Date:  2009-12-03

2.  The aetiology and associations of conjunctival intraepithelial neoplasia: further evidence.

Authors:  K M Waddell; R Newton
Journal:  Br J Ophthalmol       Date:  2007-01       Impact factor: 4.638

Review 3.  Updates in Ocular Surface Tumor Diagnostics.

Authors:  Afshan A Nanji; Carolina Mercado; Anat Galor; Sander Dubovy; Carol L Karp
Journal:  Int Ophthalmol Clin       Date:  2017

4.  [Adjuvant topical interferon-alpha-2b treatment in epithelial tumors of the ocular surface].

Authors:  T A Fuchsluger; C Hintschich; K-P Steuhl; D Meller
Journal:  Ophthalmologe       Date:  2006-02       Impact factor: 1.059

5.  Human papilloma virus in neoplastic and non-neoplastic conditions of the external eye.

Authors:  Z A Karcioglu; T M Issa
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

Review 6.  Human Papilloma Virus Vaccination and Incidence of Ocular Surface Squamous Neoplasia.

Authors:  Joy N Carroll; Zachary I Willis; Annabelle de St Maurice; Sahar Kohanim
Journal:  Int Ophthalmol Clin       Date:  2017

7.  Intraepithelial and invasive squamous cell carcinoma of the conjunctiva: analysis of 60 cases.

Authors:  M Tunc; D H Char; B Crawford; T Miller
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

8.  Surgical excision, cryotherapy, autolimbal transplantation and mitomycin-C in treatment of conjunctival-corneal intraepithelial neoplasia.

Authors:  Selim Doganay; Hamdi Er; Ahmet Tasar; Iclal Gürses
Journal:  Int Ophthalmol       Date:  2006-06-16       Impact factor: 2.031

9.  Risk factors for conjunctival squamous cell neoplasia: a matched case-control study.

Authors:  W Tulvatana; P Bhattarakosol; L Sansopha; W Sipiyarak; E Kowitdamrong; T Paisuntornsug; S Karnsawai
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

10.  Expression of p16 in conjunctival intraepithelial neoplasia does not correlate with HPV-infection.

Authors:  Claudia Auw-Haedrich; Gottfried Martin; Helga Spelsberg; Rainer Sundmacher; Nikolaus Freudenberg; Philip Maier; Thomas Reinhard
Journal:  Open Ophthalmol J       Date:  2008-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.